GZMB and neoplasm: Therefore, we further characterized the T cell phenotype, focusing on markers associated with anti-tumor immunity, in the form of immune checkpoint receptors (PD1, TIGIT, TIM3, ICOS) and other markers of T cell functionality (Granzyme-B, Ki67, Th-subsets) (gating strategy Supplementary Fig. 6).